Gene to GMP.
Faster, Higher, Smarter
Partner with a global CDMO with
FDA/EMA-compliant facilities.
Gene to GMP.
Faster, Higher, Smarter
Partner with a global CDMO with
FDA/EMA-compliant facilities.
Syngene Recombinant Protein Services
Comprehensive Recombinant Protein Services, From Gene to GMP
Syngene offers end-to-end solutions for recombinant protein production — from gene cloning and expression optimization across diverse host systems to large-scale manufacturing for pre-clinical and clinical development.
At the core is our SynWeaveâ„¢ rapid protein production platform, which boosts efficiency, shortens timelines, and delivers consistently high yields.
Our services span a broad spectrum of protein types, including monoclonal antibodies (mAbs), biosimilars, bispecific antibodies, and other biologics — helping clients bring novel therapies to market faster, with confidence.
SynWeaveâ„¢ Advantage
SynWeave™ integrates cutting-edge ExcellGene transposon technology with Syngene’s process expertise to deliver titers up to 12 g/L — reducing development timelines by as much as 10 weeks.
10 weeks faster to
pre-clinical/clinical
7–12 g/L titers
achieved
Global GMP sites in
India & US
End-to-end services
from gene to GMP
Capabilities at a Glance
End-to-End Recombinant Protein Services
Integrated Services
End-to-end gene-to-protein offerings—starting with gene synthesis and optimization, culminating in high-purity, ready-to-use recombinant proteins.
Rapid Protein Production Platform (SynWeaveâ„¢)
End-to-end gene-to-protein offerings—starting with gene synthesis and optimization, culminating in high-purity, ready-to-use recombinant proteins.
Versatile Host Systems
Expertise across mammalian, bacterial, yeast, and insect cell systems to support diverse protein types and applications.
Broad Range of Protein Types
Expertise across mammalian, bacterial, yeast, and insect cell systems to support diverse protein types and applications.
Manufacturing Capabilities
Mammalian and microbial GMP manufacturing with single-use technology platforms, dedicated suites, and multi-product campaigns.
Focus on Efficiency
SynWeaveâ„¢ reduces development timelines by up to 10 weeks, accelerating preclinical, clinical, and commercial milestones.
Applications
Recombinant proteins for immunogens, bioassays, in vitro/ in vivo studies, structural biology, and therapeutic development.
SynWeaveâ„¢ Advantage
SynWeaveâ„¢:
Redefining Protein Production
SynWeave™ leverages state-of-the-art cell line and transposon-based technologies, integrates ExcellGene’s advanced transposon-based cell line technology with Syngene’s process development expertise. The result: faster, more reliable recombinant protein production with superior manufacturability and efficiency.
Accelerated Development
Saves up to 10 weeks compared to traditional methods, streamlining timelines from preclinical to clinical milestones.
Increased Productivity
Achieves high titers of up to 12 g/L, delivering consistently high yields.
Versatile Application
Supports a broad range of biologics — including mAbs, biosimilars, bispecifics, ADCs, and glycoproteins.